70.4 F
New York
Friday, June 9, 2023



SoftWave Tissue Regeneration Technologies Enters Exclusive Distribution Agreement With Cynosure to Sell Technology in the Aesthetics and Sexual Health Markets

Related Articles

Kalamazoo Storage Center Receives Esteemed Recognition for Superior Customer Service by Loc8NearMe

Kalamazoo, MI, June 09, 2023 --(PR.com)-- In a recent accolade recognizing superior customer service and community commitment, Kalamazoo Storage Center has been honored as one...

CHALK Digital Acquires Unique Homes

San Diego, CA, June 08, 2023 --(PR.com)-- CHALK Digital today announced the acquisition of Unique Homes, the leading luxury property magazine, from duPont Publishing. The...

Press Release

Dec 22, 2021 12:00 EST

SoftWave Tissue Regeneration Technologies (SoftWave TRT) announced an exclusive agreement to supply Cynosure LLC, a global leader in medical aesthetics, with its patented extracorporeal shock wave devices for distribution in the United States and Canada primarily to medical doctors and their practices. 

“This agreement substantially increases doctors’ and patients’ access to our FDA cleared technology to accelerate healing, improve blood supply, activate connective tissue and to reduce pain and inflammation by leveraging Cynosure’s impeccable reputation and extensive sales force and marketing team,” says John Warlick, CEO of SoftWave Tissue Regeneration Technologies. “This agreement should quadruple our installed base over the next three years and provide extraordinary outcomes and…

Read more…

Popular Articles